Detalles de la búsqueda
1.
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.
Lancet Oncol
; 17(9): 1283-94, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27451390
2.
Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.
J Immunol
; 192(6): 2622-33, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24516200
3.
Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
Int J Cancer
; 135(4): 862-70, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24474335
4.
Distinct effects of saracatinib on memory CD8+ T cell differentiation.
J Immunol
; 188(9): 4323-33, 2012 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22450814
5.
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Int J Cancer
; 133(3): 624-36, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23364915
6.
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy.
Int J Cancer
; 130(8): 1948-59, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21633954
7.
Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine.
Int J Cancer
; 127(7): 1603-13, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20091862
8.
TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression.
Cancer Immunol Immunother
; 58(11): 1809-18, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19319531
9.
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.
J Clin Oncol
; 36(14): 1428-1439, 2018 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29584546
10.
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
J Clin Oncol
; 36(10): 942-950, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29394125
11.
Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.
Cancer Immunol Res
; 4(9): 755-65, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27485137
12.
Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack.
J Immunother Cancer
; 3: 52, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26579226
13.
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 1(8): 1087-95, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26291768
14.
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.
Cancer Immunol Res
; 2(11): 1090-102, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092771
15.
Therapeutic cancer vaccines.
Adv Cancer Res
; 121: 67-124, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24889529
16.
Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer.
Cancer Immunol Res
; 2(2): 133-41, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24778277
17.
Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model.
Clin Cancer Res
; 19(22): 6205-18, 2013 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24048332
18.
Effects of conventional therapeutic interventions on the number and function of regulatory T cells.
Oncoimmunology
; 2(10): e27025, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24353914
19.
The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
Semin Oncol
; 39(3): 323-39, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22595055
Resultados
1 -
19
de 19
1
Próxima >
>>